Cannabis and Cannabinoid Research

Papers
(The H4-Index of Cannabis and Cannabinoid Research is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Case in Context: Acne Inversa (Hidradenitis Suppurativa)82
Intra-Accumbal D1- But not D2-Like Dopamine Receptor Antagonism Reverses the Inhibitory Effects of Cannabidiol on Extinction and Reinstatement of Methamphetamine Seeking Behavior in Rats52
A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students43
Brain Penetrant, but not Peripherally Restricted, Synthetic Cannabinoid 1 Receptor Agonists Promote Morphine-Mediated Respiratory Depression42
Cannabidiol Marketing Strategies in the United States: An Analysis of Three Prominent Companies40
Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment40
Understanding and Rebalancing: A Rapid Scoping Review of Cannabis Research Among Indigenous People39
Typical Hits, Grams, or Joints: Evaluating Cannabis Survey Measurement Strategies for Quantifying Consumption38
Endocannabinoid System Biomarkers in Alzheimer's Disease37
The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder36
Pharmacokinetics of Oral Minor Cannabinoids in Blood and Brain31
Cannabis Use and Biomarkers of Inflammation, Immune Activation, and Microbial Translocation in Persons with HIV31
Prosocial Effects of Nonpsychotropic Cannabis sativa in Mice29
A Preliminary Pharmacokinetic Comparison of Δ-9 Tetrahydrocannabinol and Cannabidiol Extract Versus Oromucosal Spray in Healthy Men and Women29
Stakeholders' Decisions and Preferences for the Provision and Use of Medicinal Cannabis: A Scoping Review28
Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient27
Comparative Pharmacokinetic Assessment of Innovative Sublingual, Rectal and Vaporizer Cannabis Products Versus Approved Cannabis Products in Healthy Volunteers27
Therapeutic Effects of Non-Euphorigenic Cannabis Extracts in Osteoarthritis26
The Utility of THC Cutoff Levels in Blood and Saliva for Detection of Impaired Driving26
A Scoping Review on the Medical and Recreational Use of Cannabis During the COVID-19 Pandemic26
An Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry26
Kinetics of CBD, Δ9-THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions26
Genome-Wide Identification and Expression Profiles of bZIP Genes in Cannabis sativa L.26
Call for Special Issue Papers: Cannabidiol26
Letter to the Editor: Response to Dr. Mousavi’s Comments on Ogunsola et al25
0.058779001235962